title: Jaw osteonecrosis associated with intravenous bisphosphonate: is incidence reduced after adoption of dental preventive measures?
authors.forename: Vittorio
authors.initials: V
authors.lastname: Fusco
authors.forename: Anna
authors.initials: A
authors.lastname: Baraldi
authors.forename: Anastasios
authors.initials: A
authors.lastname: Loidoris
authors.forename: Libero
authors.initials: L
authors.lastname: Ciuffreda
authors.forename: Claudia
authors.initials: C
authors.lastname: Galassi
authors.forename: Franco
authors.initials: F
authors.lastname: Goia
authors.forename: Matteo
authors.initials: M
authors.lastname: Scoletta
authors.forename: Sid
authors.initials: S
authors.lastname: Berrone
authors.forename: Arnaldo
authors.initials: A
authors.lastname: Benech
authors.forename: Cinzia
authors.initials: C
authors.lastname: Ortega
authors.forename: Alfredo
authors.initials: A
authors.lastname: Berruti
mesh_terms: D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003777:Dental Prophylaxis; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007275:Injections, Intravenous; D007571:Jaw Diseases / Q000139:chemically induced* / Q000517:prevention & control; D010020:Osteonecrosis / Q000139:chemically induced* / Q000517:prevention & control; D016016:Proportional Hazards Models; D013997:Time Factors
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates